New cancer drug QXL138AM enters first human trials
Disease control
Recruiting now
This early-phase study tests a new drug, QXL138AM, for safety and tolerability in about 100 people with advanced solid tumors (like ovarian, pancreatic, or lung cancer) or multiple myeloma. Participants must have tried standard treatments without success. The study will also look…
Phase: PHASE1 • Sponsor: Nammi Therapeutics Inc • Aim: Disease control
Last updated May 22, 2026 13:51 UTC